Novel motif:154: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:22, 9 September 2013
name: | motif154_GRWGGCAARCG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 9.510165e-10 |
GO:0008612 | peptidyl-lysine modification to hypusine | 2.423688e-8 |
GO:0015858 | nucleoside transport | 4.683681e-8 |
GO:0018208 | peptidyl-proline modification | 6.227374e-8 |
GO:0007522 | visceral muscle development | 6.911573e-8 |
GO:0045652 | regulation of megakaryocyte differentiation | 8.513926e-8 |
GO:0060669 | embryonic placenta morphogenesis | 1.633239e-7 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 2.763103e-7 |
GO:0060216 | definitive hemopoiesis | 3.592145e-7 |
GO:0060070 | canonical Wnt receptor signaling pathway | 6.088694e-7 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 6.323922e-7 |
GO:0032964 | collagen biosynthetic process | 1.449499e-6 |
GO:0051488 | activation of anaphase-promoting complex activity | 1.479226e-6 |
GO:0050975 | sensory perception of touch | 1.905056e-6 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 1.935613e-6 |
GO:0030431 | sleep | 2.112258e-6 |
GO:0034447 | very-low-density lipoprotein particle clearance | 2.160016e-6 |
GO:0000413 | protein peptidyl-prolyl isomerization | 2.306836e-6 |
GO:0045905 | positive regulation of translational termination | 2.418630e-6 |
GO:0045901 | positive regulation of translational elongation | 2.418630e-6 |
GO:0006452 | translational frameshifting | 2.418630e-6 |
GO:0042270 | protection from natural killer cell mediated cytotoxicity | 2.429187e-6 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 2.633634e-6 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 3.063328e-6 |
GO:0045654 | positive regulation of megakaryocyte differentiation | 3.201846e-6 |
GO:0006449 | regulation of translational termination | 3.579872e-6 |
GO:0022009 | central nervous system vasculogenesis | 4.645084e-6 |
GO:0033233 | regulation of protein sumoylation | 5.894754e-6 |
GO:0061028 | establishment of endothelial barrier | 7.043044e-6 |
GO:0030111 | regulation of Wnt receptor signaling pathway | 7.164727e-6 |
GO:0060346 | bone trabecula formation | 7.592892e-6 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 7.924092e-6 |
GO:0060670 | branching involved in embryonic placenta morphogenesis | 9.351491e-6 |
GO:0030953 | astral microtubule organization | 9.550521e-6 |
GO:0002268 | follicular dendritic cell differentiation | 9.792320e-6 |
GO:0030309 | poly-N-acetyllactosamine metabolic process | 9.877730e-6 |
GO:0034505 | tooth mineralization | 1.088199e-5 |
GO:0032006 | regulation of TOR signaling cascade | 1.190448e-5 |
GO:0070345 | negative regulation of fat cell proliferation | 1.518852e-5 |
GO:0050690 | regulation of defense response to virus by virus | 1.538481e-5 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 1.755084e-5 |
GO:0001694 | histamine biosynthetic process | 1.867688e-5 |
GO:0045064 | T-helper 2 cell differentiation | 1.867688e-5 |
GO:0045575 | basophil activation | 1.867688e-5 |
GO:0002315 | marginal zone B cell differentiation | 1.867688e-5 |
GO:0045820 | negative regulation of glycolysis | 1.896663e-5 |
GO:0031668 | cellular response to extracellular stimulus | 1.967551e-5 |
GO:0072526 | pyridine-containing compound catabolic process | 2.048513e-5 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 2.252920e-5 |
GO:0003002 | regionalization | 2.463083e-5 |
GO:0045112 | integrin biosynthetic process | 2.602987e-5 |
GO:0032008 | positive regulation of TOR signaling cascade | 2.611837e-5 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 2.955025e-5 |
GO:0007379 | segment specification | 3.272469e-5 |
GO:0003057 | regulation of the force of heart contraction by chemical signal | 3.295931e-5 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 3.660076e-5 |
GO:0007006 | mitochondrial membrane organization | 3.863230e-5 |
GO:0009792 | embryo development ending in birth or egg hatching | 3.879329e-5 |
GO:0030311 | poly-N-acetyllactosamine biosynthetic process | 4.040802e-5 |
GO:0048384 | retinoic acid receptor signaling pathway | 4.370394e-5 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 4.387657e-5 |
GO:0003230 | cardiac atrium development | 4.445809e-5 |
GO:0003209 | cardiac atrium morphogenesis | 5.210572e-5 |
GO:0010624 | regulation of Schwann cell proliferation | 5.419098e-5 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 6.057800e-5 |
GO:0006513 | protein monoubiquitination | 6.448345e-5 |
GO:0035854 | eosinophil fate commitment | 6.957600e-5 |
GO:0030222 | eosinophil differentiation | 6.957600e-5 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 7.255813e-5 |
GO:0002026 | regulation of the force of heart contraction | 7.427526e-5 |
GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase | 7.547721e-5 |
GO:0016055 | Wnt receptor signaling pathway | 8.127230e-5 |
GO:0030277 | maintenance of gastrointestinal epithelium | 8.144125e-5 |
GO:0001661 | conditioned taste aversion | 8.440761e-5 |
GO:0040015 | negative regulation of multicellular organism growth | 8.474418e-5 |
GO:0016188 | synaptic vesicle maturation | 8.675091e-5 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 8.689692e-5 |
GO:0006457 | protein folding | 8.804673e-5 |
GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway | 9.056472e-5 |
GO:0032506 | cytokinetic process | 1.073492e-4 |
GO:0043009 | chordate embryonic development | 1.094720e-4 |
GO:0061383 | trabecula morphogenesis | 1.123748e-4 |
GO:0048488 | synaptic vesicle endocytosis | 1.223509e-4 |
GO:0048702 | embryonic neurocranium morphogenesis | 1.276444e-4 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 1.276444e-4 |
GO:0060343 | trabecula formation | 1.343635e-4 |
GO:0048755 | branching morphogenesis of a nerve | 1.346405e-4 |
GO:0042696 | menarche | 1.351543e-4 |
GO:0031330 | negative regulation of cellular catabolic process | 1.422718e-4 |
GO:0072268 | pattern specification involved in metanephros development | 1.440411e-4 |
GO:0048706 | embryonic skeletal system development | 1.486793e-4 |
GO:0007585 | respiratory gaseous exchange | 1.491515e-4 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 1.521676e-4 |
GO:0072133 | metanephric mesenchyme morphogenesis | 1.521787e-4 |
GO:0033235 | positive regulation of protein sumoylation | 1.535241e-4 |
GO:0051764 | actin crosslink formation | 1.536655e-4 |
GO:0006333 | chromatin assembly or disassembly | 1.608229e-4 |
GO:2000370 | positive regulation of clathrin-mediated endocytosis | 1.655360e-4 |
GO:0045234 | protein palmitoleylation | 1.655360e-4 |
GO:0006948 | induction by virus of host cell-cell fusion | 1.655360e-4 |
GO:0072075 | metanephric mesenchyme development | 1.690606e-4 |
GO:0035518 | histone H2A monoubiquitination | 1.810083e-4 |
GO:0048790 | maintenance of presynaptic active zone structure | 1.829510e-4 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 1.829510e-4 |
GO:0043149 | stress fiber assembly | 1.851735e-4 |
GO:0060339 | negative regulation of type I interferon-mediated signaling pathway | 1.901386e-4 |
GO:0072162 | metanephric mesenchymal cell differentiation | 1.927190e-4 |
GO:0000920 | cytokinetic cell separation | 2.044195e-4 |
GO:0060535 | trachea cartilage morphogenesis | 2.073542e-4 |
GO:0010390 | histone monoubiquitination | 2.125354e-4 |
GO:0060534 | trachea cartilage development | 2.166108e-4 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 2.169050e-4 |
GO:0060484 | lung-associated mesenchyme development | 2.227141e-4 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 2.268440e-4 |
GO:0001692 | histamine metabolic process | 2.379641e-4 |
GO:0030219 | megakaryocyte differentiation | 2.442696e-4 |
GO:0035313 | wound healing, spreading of epidermal cells | 2.662887e-4 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 2.685913e-4 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 2.720591e-4 |
GO:0071934 | thiamine transmembrane transport | 2.720591e-4 |
GO:0070078 | histone H3-R2 demethylation | 2.772184e-4 |
GO:0070079 | histone H4-R3 demethylation | 2.772184e-4 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 2.772184e-4 |
GO:0006438 | valyl-tRNA aminoacylation | 2.772184e-4 |
GO:0071496 | cellular response to external stimulus | 2.842470e-4 |
GO:0090102 | cochlea development | 2.932285e-4 |
GO:0051403 | stress-activated MAPK cascade | 2.941691e-4 |
GO:0001885 | endothelial cell development | 3.026862e-4 |
GO:0006337 | nucleosome disassembly | 3.049521e-4 |
GO:0090342 | regulation of cell aging | 3.094834e-4 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 3.202088e-4 |
GO:0071333 | cellular response to glucose stimulus | 3.294356e-4 |
GO:0031324 | negative regulation of cellular metabolic process | 3.730788e-4 |
GO:0032312 | regulation of ARF GTPase activity | 3.851377e-4 |
GO:0070483 | detection of hypoxia | 3.905559e-4 |
GO:0010171 | body morphogenesis | 4.033324e-4 |
GO:0021633 | optic nerve structural organization | 4.065987e-4 |
GO:2000597 | positive regulation of optic nerve formation | 4.065987e-4 |
GO:0061360 | optic chiasma development | 4.065987e-4 |
GO:0035799 | ureter maturation | 4.065987e-4 |
GO:0021650 | vestibulocochlear nerve formation | 4.065987e-4 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 4.173480e-4 |
GO:0060323 | head morphogenesis | 4.200098e-4 |
GO:0046724 | oxalic acid secretion | 4.495461e-4 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 4.495461e-4 |
GO:0046902 | regulation of mitochondrial membrane permeability | 4.510060e-4 |
GO:0090103 | cochlea morphogenesis | 4.595894e-4 |
GO:0072194 | kidney smooth muscle tissue development | 4.751015e-4 |
GO:0007109 | cytokinesis, completion of separation | 4.784650e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 4.862997e-4 |
GO:0032233 | positive regulation of actin filament bundle assembly | 4.883866e-4 |
GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity | 4.949825e-4 |
GO:0032425 | positive regulation of mismatch repair | 4.985738e-4 |
GO:0031396 | regulation of protein ubiquitination | 5.003517e-4 |
GO:0010832 | negative regulation of myotube differentiation | 5.029949e-4 |
GO:2000210 | positive regulation of anoikis | 5.161349e-4 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 5.167702e-4 |
GO:0032012 | regulation of ARF protein signal transduction | 5.229125e-4 |
GO:0006206 | pyrimidine base metabolic process | 5.434802e-4 |
GO:0032963 | collagen metabolic process | 5.474157e-4 |
GO:0019370 | leukotriene biosynthetic process | 5.551455e-4 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 5.732218e-4 |
GO:0030327 | prenylated protein catabolic process | 5.814613e-4 |
GO:0048705 | skeletal system morphogenesis | 5.963504e-4 |
GO:0034126 | positive regulation of MyD88-dependent toll-like receptor signaling pathway | 6.015018e-4 |
GO:0007217 | tachykinin receptor signaling pathway | 6.049258e-4 |
GO:0031397 | negative regulation of protein ubiquitination | 6.084818e-4 |
GO:0043585 | nose morphogenesis | 6.145030e-4 |
GO:0006338 | chromatin remodeling | 6.514817e-4 |
GO:0045585 | positive regulation of cytotoxic T cell differentiation | 6.590057e-4 |
GO:0002448 | mast cell mediated immunity | 6.639526e-4 |
GO:0071322 | cellular response to carbohydrate stimulus | 7.125883e-4 |
GO:0034728 | nucleosome organization | 7.145723e-4 |
GO:0033689 | negative regulation of osteoblast proliferation | 7.176697e-4 |
GO:0018199 | peptidyl-glutamine modification | 7.246512e-4 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 7.391789e-4 |
GO:0010605 | negative regulation of macromolecule metabolic process | 7.946354e-4 |
GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 8.122702e-4 |
GO:0001909 | leukocyte mediated cytotoxicity | 8.406206e-4 |
GO:0046339 | diacylglycerol metabolic process | 8.632230e-4 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 8.757062e-4 |
GO:0022027 | interkinetic nuclear migration | 8.757062e-4 |
GO:0016574 | histone ubiquitination | 9.090021e-4 |
GO:0010625 | positive regulation of Schwann cell proliferation | 9.121741e-4 |
GO:0051445 | regulation of meiotic cell cycle | 9.329981e-4 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 9.759526e-4 |
GO:0014037 | Schwann cell differentiation | 9.779315e-4 |
GO:0021759 | globus pallidus development | 9.820759e-4 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 9.820759e-4 |
GO:0060325 | face morphogenesis | 1.004239e-3 |
GO:0046101 | hypoxanthine biosynthetic process | 1.005344e-3 |
GO:0046967 | cytosol to ER transport | 1.010282e-3 |
GO:0044236 | multicellular organismal metabolic process | 1.014167e-3 |
GO:0034198 | cellular response to amino acid starvation | 1.029122e-3 |
GO:0072189 | ureter development | 1.055206e-3 |
GO:0072061 | inner medullary collecting duct development | 1.097650e-3 |
GO:0072060 | outer medullary collecting duct development | 1.097650e-3 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 1.097650e-3 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 1.111597e-3 |
GO:0035110 | leg morphogenesis | 1.119327e-3 |
GO:0015788 | UDP-N-acetylglucosamine transport | 1.132476e-3 |
GO:0002071 | glandular epithelial cell maturation | 1.132476e-3 |
GO:0007257 | activation of JUN kinase activity | 1.170269e-3 |
GO:0016568 | chromatin modification | 1.425184e-3 |
GO:0031064 | negative regulation of histone deacetylation | 1.442782e-3 |
GO:0044319 | wound healing, spreading of cells | 1.461666e-3 |
GO:0014044 | Schwann cell development | 1.463468e-3 |
GO:0003229 | ventricular cardiac muscle tissue development | 1.465278e-3 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 1.467610e-3 |
GO:0071506 | cellular response to mycophenolic acid | 1.467610e-3 |
GO:0042538 | hyperosmotic salinity response | 1.470373e-3 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 1.474673e-3 |
GO:0021562 | vestibulocochlear nerve development | 1.515013e-3 |
GO:0007296 | vitellogenesis | 1.543846e-3 |
GO:0021707 | cerebellar granule cell differentiation | 1.554897e-3 |
GO:0070208 | protein heterotrimerization | 1.577049e-3 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 1.620533e-3 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 1.620533e-3 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 1.620533e-3 |
GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response | 1.620533e-3 |
GO:0006742 | NADP catabolic process | 1.620533e-3 |
GO:0043497 | regulation of protein heterodimerization activity | 1.625532e-3 |
GO:0046755 | non-lytic virus budding | 1.656681e-3 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 1.730180e-3 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 1.737991e-3 |
GO:0007028 | cytoplasm organization | 1.742295e-3 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 1.763693e-3 |
GO:0010742 | macrophage derived foam cell differentiation | 1.772569e-3 |
GO:0002067 | glandular epithelial cell differentiation | 1.779696e-3 |
GO:0046100 | hypoxanthine metabolic process | 1.796240e-3 |
GO:0002540 | leukotriene production involved in inflammatory response | 1.834052e-3 |
GO:0071300 | cellular response to retinoic acid | 1.843351e-3 |
GO:0042398 | cellular modified amino acid biosynthetic process | 1.848599e-3 |
GO:0071299 | cellular response to vitamin A | 1.864645e-3 |
GO:0040020 | regulation of meiosis | 1.888153e-3 |
GO:0007249 | I-kappaB kinase/NF-kappaB cascade | 1.937274e-3 |
GO:0031327 | negative regulation of cellular biosynthetic process | 2.018800e-3 |
GO:0034138 | toll-like receptor 3 signaling pathway | 2.028022e-3 |
GO:0000154 | rRNA modification | 2.103790e-3 |
GO:0034389 | lipid particle organization | 2.108988e-3 |
GO:0021683 | cerebellar granular layer morphogenesis | 2.140491e-3 |
GO:0032456 | endocytic recycling | 2.143491e-3 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 2.146464e-3 |
GO:0006448 | regulation of translational elongation | 2.155072e-3 |
GO:0060395 | SMAD protein signal transduction | 2.160039e-3 |
GO:0051253 | negative regulation of RNA metabolic process | 2.244007e-3 |
GO:0035811 | negative regulation of urine volume | 2.283824e-3 |
GO:0060020 | Bergmann glial cell differentiation | 2.300334e-3 |
GO:0008298 | intracellular mRNA localization | 2.335490e-3 |
GO:0019048 | virus-host interaction | 2.360278e-3 |
GO:0030328 | prenylcysteine catabolic process | 2.380447e-3 |
GO:0022011 | myelination in peripheral nervous system | 2.387628e-3 |
GO:0060154 | cellular process regulating host cell cycle in response to virus | 2.403456e-3 |
GO:0021508 | floor plate formation | 2.425482e-3 |
GO:0015862 | uridine transport | 2.425482e-3 |
GO:0018209 | peptidyl-serine modification | 2.442998e-3 |
GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific | 2.463429e-3 |
GO:0016191 | synaptic vesicle uncoating | 2.463429e-3 |
GO:0008616 | queuosine biosynthetic process | 2.463429e-3 |
GO:0010669 | epithelial structure maintenance | 2.464993e-3 |
GO:0072195 | kidney smooth muscle cell differentiation | 2.479654e-3 |
GO:0072105 | ureteric peristalsis | 2.479654e-3 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 2.479654e-3 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 2.479654e-3 |
GO:0060252 | positive regulation of glial cell proliferation | 2.547136e-3 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 2.547652e-3 |
GO:0009890 | negative regulation of biosynthetic process | 2.626612e-3 |
GO:0031935 | regulation of chromatin silencing | 2.663684e-3 |
GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure | 2.682547e-3 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 2.710790e-3 |
GO:0042149 | cellular response to glucose starvation | 2.748416e-3 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 2.749528e-3 |
GO:0031669 | cellular response to nutrient levels | 2.766868e-3 |
GO:0051340 | regulation of ligase activity | 2.828917e-3 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 2.834399e-3 |
GO:0010225 | response to UV-C | 2.842907e-3 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 2.843690e-3 |
GO:0046543 | development of secondary female sexual characteristics | 2.849348e-3 |
GO:0018105 | peptidyl-serine phosphorylation | 2.930341e-3 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 3.076312e-3 |
GO:0034699 | response to luteinizing hormone stimulus | 3.076312e-3 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 3.089370e-3 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.143555e-3 |
GO:0001892 | embryonic placenta development | 3.205190e-3 |
GO:0007350 | blastoderm segmentation | 3.218116e-3 |
GO:0006691 | leukotriene metabolic process | 3.233441e-3 |
GO:0042770 | signal transduction in response to DNA damage | 3.276457e-3 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 3.308432e-3 |
GO:0006545 | glycine biosynthetic process | 3.361590e-3 |
GO:0007569 | cell aging | 3.372438e-3 |
GO:0045082 | positive regulation of interleukin-10 biosynthetic process | 3.391459e-3 |
GO:0071392 | cellular response to estradiol stimulus | 3.458370e-3 |
GO:0034435 | cholesterol esterification | 3.462760e-3 |
GO:0034418 | urate biosynthetic process | 3.462760e-3 |
GO:0031427 | response to methotrexate | 3.462760e-3 |
GO:0007512 | adult heart development | 3.564264e-3 |
GO:0032269 | negative regulation of cellular protein metabolic process | 3.570033e-3 |
GO:0042428 | serotonin metabolic process | 3.571466e-3 |
GO:0034959 | endothelin maturation | 3.581611e-3 |
GO:0010816 | calcitonin catabolic process | 3.581611e-3 |
GO:0010814 | substance P catabolic process | 3.581611e-3 |
GO:0060071 | Wnt receptor signaling pathway, planar cell polarity pathway | 3.586919e-3 |
GO:2000209 | regulation of anoikis | 3.628346e-3 |
GO:0006313 | transposition, DNA-mediated | 3.674255e-3 |
GO:0001957 | intramembranous ossification | 3.706593e-3 |
GO:0060267 | positive regulation of respiratory burst | 3.723642e-3 |
GO:0001970 | positive regulation of activation of membrane attack complex | 3.723642e-3 |
GO:0043393 | regulation of protein binding | 3.733581e-3 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 3.741472e-3 |
GO:0035425 | autocrine signaling | 3.743667e-3 |
GO:0035356 | cellular triglyceride homeostasis | 3.743667e-3 |
GO:0010994 | free ubiquitin chain polymerization | 3.743667e-3 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 3.779496e-3 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 3.799668e-3 |
GO:0048147 | negative regulation of fibroblast proliferation | 3.814117e-3 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 3.846868e-3 |
GO:0044332 | Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 3.914790e-3 |
GO:0043103 | hypoxanthine salvage | 3.914790e-3 |
GO:0006110 | regulation of glycolysis | 3.953089e-3 |
GO:0019511 | peptidyl-proline hydroxylation | 3.957634e-3 |
GO:0006325 | chromatin organization | 3.976104e-3 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 4.004855e-3 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 4.041081e-3 |
GO:0009163 | nucleoside biosynthetic process | 4.090639e-3 |
GO:0060322 | head development | 4.160780e-3 |
GO:0060482 | lobar bronchus development | 4.204767e-3 |
GO:0009798 | axis specification | 4.207689e-3 |
GO:0045746 | negative regulation of Notch signaling pathway | 4.212364e-3 |
GO:0016575 | histone deacetylation | 4.280688e-3 |
GO:0033522 | histone H2A ubiquitination | 4.295577e-3 |
GO:0006544 | glycine metabolic process | 4.481803e-3 |
GO:0043174 | nucleoside salvage | 4.504863e-3 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 4.523772e-3 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 4.523772e-3 |
GO:0090224 | regulation of spindle organization | 4.528163e-3 |
GO:0001941 | postsynaptic membrane organization | 4.537941e-3 |
GO:0043496 | regulation of protein homodimerization activity | 4.588112e-3 |
GO:0060711 | labyrinthine layer development | 4.602578e-3 |
GO:2000057 | negative regulation of Wnt receptor signaling pathway involved in digestive tract morphogenesis | 4.638109e-3 |
GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 4.638109e-3 |
GO:0009822 | alkaloid catabolic process | 4.638109e-3 |
GO:0006529 | asparagine biosynthetic process | 4.638109e-3 |
GO:0006334 | nucleosome assembly | 4.689997e-3 |
GO:0060689 | cell differentiation involved in salivary gland development | 4.716921e-3 |
GO:0071504 | cellular response to heparin | 4.806966e-3 |
GO:0035566 | regulation of metanephros size | 4.836691e-3 |
GO:0006013 | mannose metabolic process | 4.911043e-3 |
GO:0008637 | apoptotic mitochondrial changes | 4.976563e-3 |
GO:0072132 | mesenchyme morphogenesis | 4.989527e-3 |
GO:0045136 | development of secondary sexual characteristics | 5.011624e-3 |
GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway | 5.060319e-3 |
GO:0022411 | cellular component disassembly | 5.122852e-3 |
GO:0046113 | nucleobase catabolic process | 5.149172e-3 |
GO:0032298 | positive regulation of DNA-dependent DNA replication initiation | 5.215241e-3 |
GO:0097037 | heme export | 5.215241e-3 |
GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway | 5.215241e-3 |
GO:0006738 | nicotinamide riboside catabolic process | 5.215241e-3 |
GO:0006148 | inosine catabolic process | 5.215241e-3 |
GO:0043088 | regulation of Cdc42 GTPase activity | 5.253041e-3 |
GO:0071167 | ribonucleoprotein complex import into nucleus | 5.263127e-3 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 5.263127e-3 |
GO:0030033 | microvillus assembly | 5.339341e-3 |
GO:0045299 | otolith mineralization | 5.382988e-3 |
GO:0010560 | positive regulation of glycoprotein biosynthetic process | 5.475152e-3 |
GO:0001510 | RNA methylation | 5.536793e-3 |
GO:0045918 | negative regulation of cytolysis | 5.559293e-3 |
GO:0021930 | cerebellar granule cell precursor proliferation | 5.569126e-3 |
GO:0045074 | regulation of interleukin-10 biosynthetic process | 5.570357e-3 |
GO:0046732 | active induction of host immune response by virus | 5.603700e-3 |
GO:0033033 | negative regulation of myeloid cell apoptosis | 5.621943e-3 |
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 5.629514e-3 |
GO:0009298 | GDP-mannose biosynthetic process | 5.629514e-3 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 5.756719e-3 |
GO:0060969 | negative regulation of gene silencing | 5.765889e-3 |
GO:0016926 | protein desumoylation | 5.829744e-3 |
GO:0042267 | natural killer cell mediated cytotoxicity | 5.926023e-3 |
GO:0000302 | response to reactive oxygen species | 5.989306e-3 |
GO:0043029 | T cell homeostasis | 6.077095e-3 |
GO:0035659 | Wnt receptor signaling pathway involved in wound healing, spreading of epidermal cells | 6.119012e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 6.119012e-3 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 6.119012e-3 |
GO:0009720 | detection of hormone stimulus | 6.119012e-3 |
GO:0014719 | satellite cell activation | 6.119012e-3 |
GO:0034436 | glycoprotein transport | 6.119012e-3 |
GO:0072331 | signal transduction by p53 class mediator | 6.143781e-3 |
GO:0071391 | cellular response to estrogen stimulus | 6.159832e-3 |
GO:0022617 | extracellular matrix disassembly | 6.274559e-3 |
GO:0070344 | regulation of fat cell proliferation | 6.324207e-3 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 6.402900e-3 |
GO:0007635 | chemosensory behavior | 6.433806e-3 |
GO:0060251 | regulation of glial cell proliferation | 6.495216e-3 |
GO:0031400 | negative regulation of protein modification process | 6.559862e-3 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 6.624842e-3 |
GO:0060456 | positive regulation of digestive system process | 6.653188e-3 |
GO:0007595 | lactation | 6.670832e-3 |
GO:0021782 | glial cell development | 6.774876e-3 |
GO:0060712 | spongiotrophoblast layer development | 6.782603e-3 |
GO:0006208 | pyrimidine base catabolic process | 6.902033e-3 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 6.943527e-3 |
GO:0035623 | renal glucose absorption | 7.007762e-3 |
GO:0046038 | GMP catabolic process | 7.007762e-3 |
GO:0002522 | leukocyte migration involved in immune response | 7.007762e-3 |
GO:0006178 | guanine salvage | 7.007762e-3 |
GO:0000088 | mitotic prophase | 7.007762e-3 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 7.082058e-3 |
GO:0060690 | epithelial cell differentiation involved in salivary gland development | 7.122146e-3 |
GO:0003032 | detection of oxygen | 7.193260e-3 |
GO:0010889 | regulation of sequestering of triglyceride | 7.208096e-3 |
GO:0060441 | epithelial tube branching involved in lung morphogenesis | 7.248144e-3 |
GO:0071383 | cellular response to steroid hormone stimulus | 7.318504e-3 |
GO:0032223 | negative regulation of synaptic transmission, cholinergic | 7.361578e-3 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 7.361578e-3 |
GO:0000414 | regulation of histone H3-K36 methylation | 7.366731e-3 |
GO:0002331 | pre-B cell allelic exclusion | 7.423028e-3 |
GO:0060324 | face development | 7.428381e-3 |
GO:0032792 | negative regulation of CREB transcription factor activity | 7.482306e-3 |
GO:0005978 | glycogen biosynthetic process | 7.725664e-3 |
GO:0001678 | cellular glucose homeostasis | 7.727691e-3 |
GO:0031936 | negative regulation of chromatin silencing | 7.754764e-3 |
GO:0090311 | regulation of protein deacetylation | 7.813542e-3 |
GO:0060707 | trophoblast giant cell differentiation | 7.847482e-3 |
GO:0043932 | ossification involved in bone remodeling | 7.863966e-3 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 7.875328e-3 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 7.987330e-3 |
GO:0031497 | chromatin assembly | 8.003811e-3 |
GO:0051126 | negative regulation of actin nucleation | 8.026852e-3 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 8.026852e-3 |
GO:0032071 | regulation of endodeoxyribonuclease activity | 8.026852e-3 |
GO:0031929 | TOR signaling cascade | 8.027192e-3 |
GO:0031296 | B cell costimulation | 8.034436e-3 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 8.062826e-3 |
GO:0072300 | positive regulation of metanephric glomerulus development | 8.138773e-3 |
GO:0010629 | negative regulation of gene expression | 8.158931e-3 |
GO:0015816 | glycine transport | 8.343429e-3 |
GO:0042723 | thiamine-containing compound metabolic process | 8.343429e-3 |
GO:0010507 | negative regulation of autophagy | 8.343429e-3 |
GO:0001300 | chronological cell aging | 8.343429e-3 |
GO:0045906 | negative regulation of vasoconstriction | 8.362506e-3 |
GO:0030719 | P granule organization | 8.481473e-3 |
GO:0030488 | tRNA methylation | 8.481473e-3 |
GO:0042355 | L-fucose catabolic process | 8.500944e-3 |
GO:0051125 | regulation of actin nucleation | 8.552264e-3 |
GO:0046588 | negative regulation of calcium-dependent cell-cell adhesion | 8.552264e-3 |
GO:0070988 | demethylation | 8.596534e-3 |
GO:0033026 | negative regulation of mast cell apoptosis | 8.662751e-3 |
GO:0071229 | cellular response to acid | 8.694462e-3 |
GO:0048627 | myoblast development | 8.722268e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 8.726329e-3 |
GO:0000072 | M phase specific microtubule process | 8.810914e-3 |
GO:0060713 | labyrinthine layer morphogenesis | 8.904285e-3 |
GO:0046102 | inosine metabolic process | 8.979652e-3 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 9.035942e-3 |
GO:0060263 | regulation of respiratory burst | 9.127392e-3 |
GO:0009649 | entrainment of circadian clock | 9.135823e-3 |
GO:0008156 | negative regulation of DNA replication | 9.191865e-3 |
GO:0021696 | cerebellar cortex morphogenesis | 9.240340e-3 |
GO:0070668 | positive regulation of mast cell proliferation | 9.245973e-3 |
GO:0051261 | protein depolymerization | 9.348688e-3 |
GO:0016570 | histone modification | 9.374391e-3 |
GO:0010830 | regulation of myotube differentiation | 9.446400e-3 |
GO:0006972 | hyperosmotic response | 9.497784e-3 |
GO:0042093 | T-helper cell differentiation | 9.516571e-3 |
GO:0007422 | peripheral nervous system development | 9.605811e-3 |
GO:0097113 | alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor clustering | 9.648545e-3 |
GO:2000143 | negative regulation of transcription initiation, DNA-dependent | 9.683717e-3 |
GO:0003406 | retinal pigment epithelium development | 9.683717e-3 |
GO:0071503 | response to heparin | 9.726021e-3 |
GO:0006476 | protein deacetylation | 9.739570e-3 |
GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 9.799123e-3 |
GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 9.799123e-3 |
GO:0007371 | ventral midline determination | 9.799123e-3 |
GO:0060816 | random inactivation of X chromosome | 9.799123e-3 |
GO:0060248 | detection of cell density by contact stimulus involved in contact inhibition | 9.799123e-3 |
GO:0045198 | establishment of epithelial cell apical/basal polarity | 9.997392e-3 |
GO:0035607 | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 9.997392e-3 |
GO:0048489 | synaptic vesicle transport | 1.001527e-2 |
GO:0007023 | post-chaperonin tubulin folding pathway | 1.005527e-2 |
GO:0010626 | negative regulation of Schwann cell proliferation | 1.007089e-2 |
GO:2001014 | regulation of skeletal muscle cell differentiation | 1.011026e-2 |
GO:0071295 | cellular response to vitamin | 1.013608e-2 |
GO:0071845 | cellular component disassembly at cellular level | 1.027811e-2 |
GO:0070989 | oxidative demethylation | 1.036466e-2 |
GO:0002885 | positive regulation of hypersensitivity | 1.038549e-2 |
GO:0010523 | negative regulation of calcium ion transport into cytosol | 1.047940e-2 |
GO:0030208 | dermatan sulfate biosynthetic process | 1.048627e-2 |
GO:0008589 | regulation of smoothened signaling pathway | 1.056891e-2 |
GO:0014005 | microglia development | 1.060730e-2 |
GO:0070625 | zymogen granule exocytosis | 1.060730e-2 |
GO:0015931 | nucleobase-containing compound transport | 1.063071e-2 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 1.065668e-2 |
GO:0050902 | leukocyte adhesive activation | 1.065668e-2 |
GO:0008595 | anterior/posterior axis specification, embryo | 1.067665e-2 |
GO:0042472 | inner ear morphogenesis | 1.072032e-2 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 1.078475e-2 |
GO:0030970 | retrograde protein transport, ER to cytosol | 1.078475e-2 |
GO:0046730 | induction of host immune response by virus | 1.081795e-2 |
GO:0031536 | positive regulation of exit from mitosis | 1.081795e-2 |
GO:0070904 | transepithelial L-ascorbic acid transport | 1.109421e-2 |
GO:0031167 | rRNA methylation | 1.112548e-2 |
GO:0033505 | floor plate morphogenesis | 1.112548e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0070647 | protein modification by small protein conjugation or removal | 7.525049e-17 |
GO:0016579 | protein deubiquitination | 3.124935e-12 |
GO:0016567 | protein ubiquitination | 1.651995e-10 |
GO:0070646 | protein modification by small protein removal | 6.729621e-10 |
GO:0002385 | mucosal immune response | 2.018633e-9 |
GO:0032446 | protein modification by small protein conjugation | 3.297098e-9 |
GO:0002251 | organ or tissue specific immune response | 8.340262e-9 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 9.954804e-9 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 1.535192e-8 |
GO:0006446 | regulation of translational initiation | 2.182688e-8 |
GO:0044240 | multicellular organismal lipid catabolic process | 3.125024e-8 |
GO:0002227 | innate immune response in mucosa | 3.193662e-8 |
GO:0006756 | AMP phosphorylation | 4.423721e-8 |
GO:0046034 | ATP metabolic process | 1.287595e-7 |
GO:0006482 | protein demethylation | 1.631031e-7 |
GO:0021591 | ventricular system development | 1.678971e-7 |
GO:0006982 | response to lipid hydroperoxide | 1.899492e-7 |
GO:0000910 | cytokinesis | 2.653867e-7 |
GO:0006287 | base-excision repair, gap-filling | 3.251706e-7 |
GO:0070527 | platelet aggregation | 3.994994e-7 |
GO:0070328 | triglyceride homeostasis | 4.652039e-7 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 5.195932e-7 |
GO:0016577 | histone demethylation | 5.571427e-7 |
GO:0021670 | lateral ventricle development | 8.995672e-7 |
GO:0032239 | regulation of nucleobase-containing compound transport | 9.292576e-7 |
GO:0032534 | regulation of microvillus assembly | 9.340940e-7 |
GO:0044260 | cellular macromolecule metabolic process | 9.409057e-7 |
GO:0046940 | nucleoside monophosphate phosphorylation | 1.029706e-6 |
GO:2000078 | positive regulation of type B pancreatic cell development | 1.340050e-6 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 1.594444e-6 |
GO:0046831 | regulation of RNA export from nucleus | 1.882091e-6 |
GO:0071316 | cellular response to nicotine | 2.034740e-6 |
GO:0000209 | protein polyubiquitination | 2.056720e-6 |
GO:0034728 | nucleosome organization | 2.141595e-6 |
GO:0045073 | regulation of chemokine biosynthetic process | 2.251710e-6 |
GO:0009259 | ribonucleotide metabolic process | 2.593014e-6 |
GO:0009141 | nucleoside triphosphate metabolic process | 2.649930e-6 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 2.906025e-6 |
GO:0061013 | regulation of mRNA catabolic process | 2.944806e-6 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 3.134255e-6 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 3.312616e-6 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 3.360585e-6 |
GO:0006334 | nucleosome assembly | 3.804389e-6 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 4.133045e-6 |
GO:0071157 | negative regulation of cell cycle arrest | 4.358866e-6 |
GO:0042559 | pteridine-containing compound biosynthetic process | 4.390947e-6 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 4.794967e-6 |
GO:0006139 | nucleobase-containing compound metabolic process | 5.327522e-6 |
GO:0010898 | positive regulation of triglyceride catabolic process | 5.680675e-6 |
GO:0071526 | semaphorin-plexin signaling pathway | 6.578084e-6 |
GO:0055090 | acylglycerol homeostasis | 7.344461e-6 |
GO:0043654 | recognition of apoptotic cell | 7.344461e-6 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 7.401505e-6 |
GO:0032615 | interleukin-12 production | 8.213992e-6 |
GO:0006333 | chromatin assembly or disassembly | 8.468906e-6 |
GO:0009150 | purine ribonucleotide metabolic process | 9.496548e-6 |
GO:0097022 | lymphocyte migration into lymph node | 1.029887e-5 |
GO:0072610 | interleukin-12 secretion | 1.029887e-5 |
GO:0009404 | toxin metabolic process | 1.056059e-5 |
GO:0032530 | regulation of microvillus organization | 1.070251e-5 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 1.265924e-5 |
GO:0031914 | negative regulation of synaptic plasticity | 1.266723e-5 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.420725e-5 |
GO:0070988 | demethylation | 1.439377e-5 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 1.459349e-5 |
GO:0051301 | cell division | 1.545570e-5 |
GO:0031129 | inductive cell-cell signaling | 1.630690e-5 |
GO:0006807 | nitrogen compound metabolic process | 1.802031e-5 |
GO:0071824 | protein-DNA complex subunit organization | 1.907148e-5 |
GO:0035621 | ER to Golgi ceramide transport | 1.921259e-5 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 1.921259e-5 |
GO:0015747 | urate transport | 2.091171e-5 |
GO:0002675 | positive regulation of acute inflammatory response | 2.125592e-5 |
GO:0097026 | dendritic cell dendrite assembly | 2.144384e-5 |
GO:0046341 | CDP-diacylglycerol metabolic process | 2.144384e-5 |
GO:0060591 | chondroblast differentiation | 2.147764e-5 |
GO:0030048 | actin filament-based movement | 2.526460e-5 |
GO:0051298 | centrosome duplication | 2.627709e-5 |
GO:0006325 | chromatin organization | 3.124112e-5 |
GO:0033131 | regulation of glucokinase activity | 3.189566e-5 |
GO:0010890 | positive regulation of sequestering of triglyceride | 3.341541e-5 |
GO:0031440 | regulation of mRNA 3'-end processing | 3.426453e-5 |
GO:0021993 | initiation of neural tube closure | 3.498563e-5 |
GO:0044241 | lipid digestion | 4.862124e-5 |
GO:0032648 | regulation of interferon-beta production | 5.117350e-5 |
GO:0044267 | cellular protein metabolic process | 5.119349e-5 |
GO:0043303 | mast cell degranulation | 5.234270e-5 |
GO:0032479 | regulation of type I interferon production | 5.259367e-5 |
GO:0002275 | myeloid cell activation involved in immune response | 5.544373e-5 |
GO:0006163 | purine nucleotide metabolic process | 6.009450e-5 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 6.189153e-5 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 6.305934e-5 |
GO:0021528 | commissural neuron differentiation in spinal cord | 6.465123e-5 |
GO:0021678 | third ventricle development | 7.220792e-5 |
GO:0031349 | positive regulation of defense response | 7.259810e-5 |
GO:0031497 | chromatin assembly | 7.292298e-5 |
GO:0009117 | nucleotide metabolic process | 7.330951e-5 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 7.680563e-5 |
GO:0001768 | establishment of T cell polarity | 7.747416e-5 |
GO:0090042 | tubulin deacetylation | 8.544564e-5 |
GO:0030222 | eosinophil differentiation | 8.544564e-5 |
GO:0070846 | Hsp90 deacetylation | 8.544564e-5 |
GO:0019067 | viral assembly, maturation, egress, and release | 8.879526e-5 |
GO:0006464 | protein modification process | 9.575015e-5 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 9.612778e-5 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 1.001986e-4 |
GO:0046483 | heterocycle metabolic process | 1.010257e-4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.031321e-4 |
GO:0033136 | serine phosphorylation of STAT3 protein | 1.034238e-4 |
GO:0042558 | pteridine-containing compound metabolic process | 1.129362e-4 |
GO:0008063 | Toll signaling pathway | 1.148902e-4 |
GO:0030878 | thyroid gland development | 1.294555e-4 |
GO:0006868 | glutamine transport | 1.353455e-4 |
GO:0065004 | protein-DNA complex assembly | 1.378958e-4 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 1.402631e-4 |
GO:0031115 | negative regulation of microtubule polymerization | 1.478832e-4 |
GO:0070634 | transepithelial ammonium transport | 1.493369e-4 |
GO:0021592 | fourth ventricle development | 1.493369e-4 |
GO:0002885 | positive regulation of hypersensitivity | 1.499470e-4 |
GO:0007049 | cell cycle | 1.538188e-4 |
GO:0034442 | regulation of lipoprotein oxidation | 1.546945e-4 |
GO:0055118 | negative regulation of cardiac muscle contraction | 1.647238e-4 |
GO:0003209 | cardiac atrium morphogenesis | 1.679259e-4 |
GO:0018130 | heterocycle biosynthetic process | 1.710410e-4 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 1.861640e-4 |
GO:0045624 | positive regulation of T-helper cell differentiation | 1.905489e-4 |
GO:0071474 | cellular hyperosmotic response | 1.972377e-4 |
GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development | 2.011934e-4 |
GO:0090304 | nucleic acid metabolic process | 2.034879e-4 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 2.063002e-4 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 2.205345e-4 |
GO:0033504 | floor plate development | 2.224630e-4 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.314985e-4 |
GO:0045064 | T-helper 2 cell differentiation | 2.381125e-4 |
GO:0090208 | positive regulation of triglyceride metabolic process | 2.475932e-4 |
GO:0006415 | translational termination | 2.592932e-4 |
GO:0015804 | neutral amino acid transport | 2.605097e-4 |
GO:0070076 | histone lysine demethylation | 2.697155e-4 |
GO:0015696 | ammonium transport | 2.717011e-4 |
GO:0050685 | positive regulation of mRNA processing | 2.723066e-4 |
GO:0031329 | regulation of cellular catabolic process | 2.769436e-4 |
GO:0007522 | visceral muscle development | 2.849781e-4 |
GO:0010870 | positive regulation of receptor biosynthetic process | 2.851217e-4 |
GO:0016584 | nucleosome positioning | 2.916575e-4 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 3.073404e-4 |
GO:0003341 | cilium movement | 3.107674e-4 |
GO:0043170 | macromolecule metabolic process | 3.132318e-4 |
GO:0010467 | gene expression | 3.196945e-4 |
GO:0090107 | regulation of high-density lipoprotein particle assembly | 3.227389e-4 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 3.227389e-4 |
GO:0014050 | negative regulation of glutamate secretion | 3.278725e-4 |
GO:0002649 | regulation of tolerance induction to self antigen | 3.278725e-4 |
GO:0044237 | cellular metabolic process | 3.324858e-4 |
GO:0009894 | regulation of catabolic process | 3.336428e-4 |
GO:0046929 | negative regulation of neurotransmitter secretion | 3.547884e-4 |
GO:0035435 | phosphate ion transmembrane transport | 3.547884e-4 |
GO:0006777 | Mo-molybdopterin cofactor biosynthetic process | 3.553738e-4 |
GO:0032796 | uropod organization | 3.562194e-4 |
GO:0046931 | pore complex assembly | 3.562194e-4 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 3.723786e-4 |
GO:0031331 | positive regulation of cellular catabolic process | 3.731716e-4 |
GO:0035584 | calcium-mediated signaling using intracellular calcium source | 3.752583e-4 |
GO:0045055 | regulated secretory pathway | 3.753383e-4 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 3.796342e-4 |
GO:0006941 | striated muscle contraction | 3.797969e-4 |
GO:0046755 | non-lytic virus budding | 3.869717e-4 |
GO:0045226 | extracellular polysaccharide biosynthetic process | 3.869717e-4 |
GO:0007099 | centriole replication | 3.996620e-4 |
GO:0045988 | negative regulation of striated muscle contraction | 4.054220e-4 |
GO:0044243 | multicellular organismal catabolic process | 4.313108e-4 |
GO:0072521 | purine-containing compound metabolic process | 4.589241e-4 |
GO:0046328 | regulation of JNK cascade | 4.730149e-4 |
GO:0001771 | immunological synapse formation | 4.739694e-4 |
GO:0070544 | histone H3-K36 demethylation | 4.781283e-4 |
GO:0072522 | purine-containing compound biosynthetic process | 4.800089e-4 |
GO:0033205 | cell cycle cytokinesis | 4.917291e-4 |
GO:0048143 | astrocyte activation | 4.936353e-4 |
GO:0044342 | type B pancreatic cell proliferation | 5.001824e-4 |
GO:0031323 | regulation of cellular metabolic process | 5.009063e-4 |
GO:0060711 | labyrinthine layer development | 5.095310e-4 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 5.263976e-4 |
GO:0050892 | intestinal absorption | 5.277112e-4 |
GO:0009435 | NAD biosynthetic process | 5.343420e-4 |
GO:0051276 | chromosome organization | 5.483314e-4 |
GO:0051569 | regulation of histone H3-K4 methylation | 5.573637e-4 |
GO:0006914 | autophagy | 5.592580e-4 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 5.661063e-4 |
GO:0002758 | innate immune response-activating signal transduction | 5.854521e-4 |
GO:0023035 | CD40 signaling pathway | 5.882187e-4 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 5.882187e-4 |
GO:0000725 | recombinational repair | 5.934050e-4 |
GO:0070633 | transepithelial transport | 5.965875e-4 |
GO:0015074 | DNA integration | 5.965875e-4 |
GO:0002518 | lymphocyte chemotaxis across high endothelial venule | 5.990912e-4 |
GO:2000412 | positive regulation of thymocyte migration | 5.990912e-4 |
GO:0006680 | glucosylceramide catabolic process | 6.067782e-4 |
GO:0033132 | negative regulation of glucokinase activity | 6.132098e-4 |
GO:0030505 | inorganic diphosphate transport | 6.132098e-4 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 6.294486e-4 |
GO:0006657 | CDP-choline pathway | 6.294486e-4 |
GO:0072488 | ammonium transmembrane transport | 6.420509e-4 |
GO:0006491 | N-glycan processing | 6.453371e-4 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 6.497036e-4 |
GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 6.740742e-4 |
GO:0043549 | regulation of kinase activity | 7.032557e-4 |
GO:0030730 | sequestering of triglyceride | 7.127277e-4 |
GO:0055119 | relaxation of cardiac muscle | 7.127277e-4 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 7.552339e-4 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 7.950939e-4 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 7.950939e-4 |
GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway | 7.950939e-4 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | 7.962712e-4 |
GO:0016236 | macroautophagy | 7.975161e-4 |
GO:0045579 | positive regulation of B cell differentiation | 7.992056e-4 |
GO:0090207 | regulation of triglyceride metabolic process | 8.036882e-4 |
GO:0010629 | negative regulation of gene expression | 8.062552e-4 |
GO:0071479 | cellular response to ionizing radiation | 8.128591e-4 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 8.217191e-4 |
GO:0061298 | retina vasculature development in camera-type eye | 8.217191e-4 |
GO:0035725 | sodium ion transmembrane transport | 8.327125e-4 |
GO:0072332 | signal transduction by p53 class mediator resulting in induction of apoptosis | 8.528776e-4 |
GO:0015808 | L-alanine transport | 8.542228e-4 |
GO:0010225 | response to UV-C | 8.671535e-4 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 8.736726e-4 |
GO:0070194 | synaptonemal complex disassembly | 8.736726e-4 |
GO:0045023 | G0 to G1 transition | 8.736726e-4 |
GO:0003273 | cell migration involved in endocardial cushion formation | 8.736726e-4 |
GO:0006164 | purine nucleotide biosynthetic process | 8.921620e-4 |
GO:0033133 | positive regulation of glucokinase activity | 8.990399e-4 |
GO:0042483 | negative regulation of odontogenesis | 9.234015e-4 |
GO:0090162 | establishment of epithelial cell polarity | 9.340482e-4 |
GO:0071383 | cellular response to steroid hormone stimulus | 9.380684e-4 |
GO:0003230 | cardiac atrium development | 9.476889e-4 |
GO:0043299 | leukocyte degranulation | 9.541973e-4 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 9.578337e-4 |
GO:0051295 | establishment of meiotic spindle localization | 9.666105e-4 |
GO:0002036 | regulation of L-glutamate transport | 9.666105e-4 |
GO:0046881 | positive regulation of follicle-stimulating hormone secretion | 9.838251e-4 |
GO:0015793 | glycerol transport | 9.930218e-4 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 9.930218e-4 |
GO:0045627 | positive regulation of T-helper 1 cell differentiation | 1.080824e-3 |
GO:0010457 | centriole-centriole cohesion | 1.126955e-3 |
GO:0009108 | coenzyme biosynthetic process | 1.139009e-3 |
GO:0061014 | positive regulation of mRNA catabolic process | 1.161663e-3 |
GO:0043412 | macromolecule modification | 1.194855e-3 |
GO:0070936 | protein K48-linked ubiquitination | 1.218877e-3 |
GO:0055088 | lipid homeostasis | 1.238676e-3 |
GO:0010725 | regulation of primitive erythrocyte differentiation | 1.243085e-3 |
GO:0009637 | response to blue light | 1.243085e-3 |
GO:0080090 | regulation of primary metabolic process | 1.274202e-3 |
GO:0046329 | negative regulation of JNK cascade | 1.286717e-3 |
GO:0033522 | histone H2A ubiquitination | 1.303062e-3 |
GO:2000178 | negative regulation of neural precursor cell proliferation | 1.306981e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 1.314884e-3 |
GO:0043401 | steroid hormone mediated signaling pathway | 1.347210e-3 |
GO:0002678 | positive regulation of chronic inflammatory response | 1.395911e-3 |
GO:0060005 | vestibular reflex | 1.395911e-3 |
GO:0009987 | cellular process | 1.400270e-3 |
GO:0008286 | insulin receptor signaling pathway | 1.416461e-3 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 1.446375e-3 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 1.475323e-3 |
GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process | 1.475323e-3 |
GO:0007132 | meiotic metaphase I | 1.475323e-3 |
GO:0060370 | susceptibility to T cell mediated cytotoxicity | 1.494467e-3 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 1.494467e-3 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 1.498792e-3 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 1.508685e-3 |
GO:0010829 | negative regulation of glucose transport | 1.515095e-3 |
GO:0046325 | negative regulation of glucose import | 1.522826e-3 |
GO:0002883 | regulation of hypersensitivity | 1.526474e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.529410e-3 |
GO:0032922 | circadian regulation of gene expression | 1.529410e-3 |
GO:0006754 | ATP biosynthetic process | 1.537512e-3 |
GO:0016070 | RNA metabolic process | 1.548875e-3 |
GO:0021965 | spinal cord ventral commissure morphogenesis | 1.563265e-3 |
GO:0002407 | dendritic cell chemotaxis | 1.587551e-3 |
GO:0007143 | female meiosis | 1.596356e-3 |
GO:0072331 | signal transduction by p53 class mediator | 1.598210e-3 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.600298e-3 |
GO:0045234 | protein palmitoleylation | 1.611057e-3 |
GO:0006948 | induction by virus of host cell-cell fusion | 1.611057e-3 |
GO:0060697 | positive regulation of phospholipid catabolic process | 1.612862e-3 |
GO:0009992 | cellular water homeostasis | 1.612862e-3 |
GO:0006707 | cholesterol catabolic process | 1.633446e-3 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 1.641384e-3 |
GO:0009143 | nucleoside triphosphate catabolic process | 1.647465e-3 |
GO:0070979 | protein K11-linked ubiquitination | 1.656373e-3 |
GO:0045739 | positive regulation of DNA repair | 1.660040e-3 |
GO:0006863 | purine base transport | 1.684261e-3 |
GO:0022617 | extracellular matrix disassembly | 1.684261e-3 |
GO:0072595 | maintenance of protein localization to organelle | 1.761801e-3 |
GO:0032481 | positive regulation of type I interferon production | 1.774315e-3 |
GO:0002221 | pattern recognition receptor signaling pathway | 1.774315e-3 |
GO:0010896 | regulation of triglyceride catabolic process | 1.774315e-3 |
GO:0009755 | hormone-mediated signaling pathway | 1.798145e-3 |
GO:0042594 | response to starvation | 1.823261e-3 |
GO:0009152 | purine ribonucleotide biosynthetic process | 1.842819e-3 |
GO:0010830 | regulation of myotube differentiation | 1.870600e-3 |
GO:0050729 | positive regulation of inflammatory response | 1.927324e-3 |
GO:0030049 | muscle filament sliding | 2.022531e-3 |
GO:0044238 | primary metabolic process | 2.033073e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 2.056698e-3 |
GO:0033344 | cholesterol efflux | 2.091707e-3 |
GO:0022038 | corpus callosum development | 2.125214e-3 |
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 2.187262e-3 |
GO:0032984 | macromolecular complex disassembly | 2.288968e-3 |
GO:0051894 | positive regulation of focal adhesion assembly | 2.308659e-3 |
GO:0051798 | positive regulation of hair follicle development | 2.308659e-3 |
GO:0000724 | double-strand break repair via homologous recombination | 2.332593e-3 |
GO:0002218 | activation of innate immune response | 2.338948e-3 |
GO:0090161 | Golgi ribbon formation | 2.377598e-3 |
GO:0051338 | regulation of transferase activity | 2.402872e-3 |
GO:0009261 | ribonucleotide catabolic process | 2.411007e-3 |
GO:0071478 | cellular response to radiation | 2.411149e-3 |
GO:0032971 | regulation of muscle filament sliding | 2.424423e-3 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 2.424423e-3 |
GO:0032513 | negative regulation of protein phosphatase type 2B activity | 2.424423e-3 |
GO:0032785 | negative regulation of transcription elongation, DNA-dependent | 2.430625e-3 |
GO:0045948 | positive regulation of translational initiation | 2.437178e-3 |
GO:0042990 | regulation of transcription factor import into nucleus | 2.446200e-3 |
GO:0033275 | actin-myosin filament sliding | 2.456298e-3 |
GO:0080135 | regulation of cellular response to stress | 2.458737e-3 |
GO:0006200 | ATP catabolic process | 2.483536e-3 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.494315e-3 |
GO:0007614 | short-term memory | 2.495287e-3 |
GO:0009267 | cellular response to starvation | 2.502240e-3 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 2.544872e-3 |
GO:0001977 | renal system process involved in regulation of blood volume | 2.578942e-3 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.614822e-3 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 2.628793e-3 |
GO:0045994 | positive regulation of translational initiation by iron | 2.628793e-3 |
GO:0002037 | negative regulation of L-glutamate transport | 2.628793e-3 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 2.628793e-3 |
GO:0032506 | cytokinetic process | 2.654132e-3 |
GO:0015816 | glycine transport | 2.654132e-3 |
GO:0003093 | regulation of glomerular filtration | 2.654132e-3 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 2.743899e-3 |
GO:0045859 | regulation of protein kinase activity | 2.751288e-3 |
GO:0010889 | regulation of sequestering of triglyceride | 2.771890e-3 |
GO:0048644 | muscle organ morphogenesis | 2.777156e-3 |
GO:0060644 | mammary gland epithelial cell differentiation | 2.791966e-3 |
GO:0046939 | nucleotide phosphorylation | 2.819633e-3 |
GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 2.846106e-3 |
GO:0006687 | glycosphingolipid metabolic process | 2.890144e-3 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 2.973482e-3 |
GO:0006927 | transformed cell apoptosis | 2.973482e-3 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 2.986987e-3 |
GO:0051253 | negative regulation of RNA metabolic process | 2.990007e-3 |
GO:0019438 | aromatic compound biosynthetic process | 2.992059e-3 |
GO:0034623 | cellular macromolecular complex disassembly | 3.038847e-3 |
GO:0031398 | positive regulation of protein ubiquitination | 3.069415e-3 |
GO:0042407 | cristae formation | 3.094574e-3 |
GO:0051353 | positive regulation of oxidoreductase activity | 3.108099e-3 |
GO:0015851 | nucleobase transport | 3.108652e-3 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 3.125318e-3 |
GO:0002074 | extraocular skeletal muscle development | 3.158493e-3 |
GO:0031076 | embryonic camera-type eye development | 3.173238e-3 |
GO:0006182 | cGMP biosynthetic process | 3.208070e-3 |
GO:0009059 | macromolecule biosynthetic process | 3.259177e-3 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 3.292986e-3 |
GO:0045947 | negative regulation of translational initiation | 3.306069e-3 |
GO:0006403 | RNA localization | 3.311154e-3 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 3.346153e-3 |
GO:0034976 | response to endoplasmic reticulum stress | 3.387697e-3 |
GO:0032507 | maintenance of protein location in cell | 3.391677e-3 |
GO:0019322 | pentose biosynthetic process | 3.426605e-3 |
GO:0008643 | carbohydrate transport | 3.443407e-3 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 3.450673e-3 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 3.464021e-3 |
GO:0045089 | positive regulation of innate immune response | 3.475835e-3 |
GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 3.506388e-3 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 3.548099e-3 |
GO:0015824 | proline transport | 3.558459e-3 |
GO:0071900 | regulation of protein serine/threonine kinase activity | 3.562522e-3 |
GO:0071840 | cellular component organization or biogenesis | 3.576868e-3 |
GO:0009260 | ribonucleotide biosynthetic process | 3.605083e-3 |
GO:0007320 | insemination | 3.634440e-3 |
GO:0051764 | actin crosslink formation | 3.641569e-3 |
GO:0002426 | immunoglobulin production in mucosal tissue | 3.641569e-3 |
GO:0001829 | trophectodermal cell differentiation | 3.648030e-3 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 3.725437e-3 |
GO:0043088 | regulation of Cdc42 GTPase activity | 3.779942e-3 |
GO:0006706 | steroid catabolic process | 3.790914e-3 |
GO:0046415 | urate metabolic process | 3.836919e-3 |
GO:2000381 | negative regulation of mesoderm development | 3.839945e-3 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 3.875625e-3 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 3.909806e-3 |
GO:0006406 | mRNA export from nucleus | 3.933607e-3 |
GO:0034612 | response to tumor necrosis factor | 3.991031e-3 |
GO:0045787 | positive regulation of cell cycle | 4.075228e-3 |
GO:0070252 | actin-mediated cell contraction | 4.088275e-3 |
GO:0021930 | cerebellar granule cell precursor proliferation | 4.124218e-3 |
GO:0019371 | cyclooxygenase pathway | 4.124218e-3 |
GO:0034384 | high-density lipoprotein particle clearance | 4.170681e-3 |
GO:0034446 | substrate adhesion-dependent cell spreading | 4.230761e-3 |
GO:0006983 | ER overload response | 4.248650e-3 |
GO:0071288 | cellular response to mercury ion | 4.286513e-3 |
GO:0070845 | polyubiquitinated misfolded protein transport | 4.286513e-3 |
GO:0070094 | positive regulation of glucagon secretion | 4.286513e-3 |
GO:0070561 | vitamin D receptor signaling pathway | 4.286513e-3 |
GO:0060578 | superior vena cava morphogenesis | 4.302672e-3 |
GO:0051351 | positive regulation of ligase activity | 4.433871e-3 |
GO:0038007 | netrin-activated signaling pathway | 4.452991e-3 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 4.534651e-3 |
GO:0046889 | positive regulation of lipid biosynthetic process | 4.536651e-3 |
GO:0050965 | detection of temperature stimulus involved in sensory perception of pain | 4.625989e-3 |
GO:0023021 | termination of signal transduction | 4.625989e-3 |
GO:0045185 | maintenance of protein location | 4.645789e-3 |
GO:0043691 | reverse cholesterol transport | 4.648445e-3 |
GO:0051235 | maintenance of location | 4.658873e-3 |
GO:2000781 | positive regulation of double-strand break repair | 4.708982e-3 |
GO:0030311 | poly-N-acetyllactosamine biosynthetic process | 4.708982e-3 |
GO:0045004 | DNA replication proofreading | 4.708982e-3 |
GO:0043610 | regulation of carbohydrate utilization | 4.708982e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 4.708982e-3 |
GO:0018208 | peptidyl-proline modification | 4.901051e-3 |
GO:0009314 | response to radiation | 4.939813e-3 |
GO:0060010 | Sertoli cell fate commitment | 5.029687e-3 |
GO:0044058 | regulation of digestive system process | 5.031756e-3 |
GO:0060415 | muscle tissue morphogenesis | 5.071838e-3 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 5.108134e-3 |
GO:0016043 | cellular component organization | 5.132460e-3 |
GO:0000413 | protein peptidyl-prolyl isomerization | 5.161892e-3 |
GO:0051340 | regulation of ligase activity | 5.161892e-3 |
GO:0042771 | DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis | 5.168463e-3 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 5.234730e-3 |
GO:0030259 | lipid glycosylation | 5.273908e-3 |
GO:0043981 | histone H4-K5 acetylation | 5.275075e-3 |
GO:0043982 | histone H4-K8 acetylation | 5.275075e-3 |
GO:0000281 | cytokinesis after mitosis | 5.275075e-3 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 5.286139e-3 |
GO:0051028 | mRNA transport | 5.342017e-3 |
GO:0031669 | cellular response to nutrient levels | 5.360775e-3 |
GO:0031060 | regulation of histone methylation | 5.462021e-3 |
GO:0009166 | nucleotide catabolic process | 5.469408e-3 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 5.563693e-3 |
GO:0043407 | negative regulation of MAP kinase activity | 5.576199e-3 |
GO:0072321 | chaperone-mediated protein transport | 5.628764e-3 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 5.628764e-3 |
GO:0001705 | ectoderm formation | 5.628764e-3 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 5.655143e-3 |
GO:0042035 | regulation of cytokine biosynthetic process | 5.699282e-3 |
GO:0018198 | peptidyl-cysteine modification | 5.773424e-3 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 5.797545e-3 |
GO:0001574 | ganglioside biosynthetic process | 5.807118e-3 |
GO:0031668 | cellular response to extracellular stimulus | 5.891674e-3 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 6.079106e-3 |
GO:0048739 | cardiac muscle fiber development | 6.104976e-3 |
GO:0072239 | metanephric glomerulus vasculature development | 6.109412e-3 |
GO:0014002 | astrocyte development | 6.127108e-3 |
GO:0006688 | glycosphingolipid biosynthetic process | 6.142859e-3 |
GO:0060459 | left lung development | 6.144655e-3 |
GO:0015920 | lipopolysaccharide transport | 6.144655e-3 |
GO:0008633 | activation of pro-apoptotic gene products | 6.190880e-3 |
GO:0060685 | regulation of prostatic bud formation | 6.203825e-3 |
GO:0033146 | regulation of estrogen receptor signaling pathway | 6.203825e-3 |
GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process | 6.217016e-3 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 6.217016e-3 |
GO:0009648 | photoperiodism | 6.217016e-3 |
GO:0006261 | DNA-dependent DNA replication | 6.267561e-3 |
GO:0006476 | protein deacetylation | 6.366504e-3 |
GO:0060075 | regulation of resting membrane potential | 6.370920e-3 |
GO:0048808 | male genitalia morphogenesis | 6.381930e-3 |
GO:0048313 | Golgi inheritance | 6.425925e-3 |
GO:0034369 | plasma lipoprotein particle remodeling | 6.492054e-3 |
GO:0051150 | regulation of smooth muscle cell differentiation | 6.558216e-3 |
GO:0044249 | cellular biosynthetic process | 6.594512e-3 |
GO:0060457 | negative regulation of digestive system process | 6.734808e-3 |
GO:0005978 | glycogen biosynthetic process | 6.745552e-3 |
GO:0072230 | metanephric proximal straight tubule development | 6.764330e-3 |
GO:0051458 | corticotropin secretion | 6.764330e-3 |
GO:0072232 | metanephric proximal convoluted tubule segment 2 development | 6.764330e-3 |
GO:0085018 | maintenance of symbiont-containing vacuole via substance secreted by host | 6.764330e-3 |
GO:0002368 | B cell cytokine production | 6.764330e-3 |
GO:0048291 | isotype switching to IgG isotypes | 6.764330e-3 |
GO:0072220 | metanephric descending thin limb development | 6.764330e-3 |
GO:0046833 | positive regulation of RNA export from nucleus | 6.764330e-3 |
GO:0002525 | acute inflammatory response to non-antigenic stimulus | 6.764330e-3 |
GO:0035378 | carbon dioxide transmembrane transport | 6.764330e-3 |
GO:0035377 | transepithelial water transport | 6.764330e-3 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 6.764330e-3 |
GO:0007030 | Golgi organization | 6.768825e-3 |
GO:0006833 | water transport | 6.842340e-3 |
GO:0060558 | regulation of calcidiol 1-monooxygenase activity | 6.862593e-3 |
GO:0045622 | regulation of T-helper cell differentiation | 6.872887e-3 |
GO:0046902 | regulation of mitochondrial membrane permeability | 7.017927e-3 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 7.017927e-3 |
GO:0006396 | RNA processing | 7.026148e-3 |
GO:2000383 | regulation of ectoderm development | 7.036104e-3 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 7.036104e-3 |
GO:0071496 | cellular response to external stimulus | 7.049287e-3 |
GO:0002576 | platelet degranulation | 7.072239e-3 |
GO:0050927 | positive regulation of positive chemotaxis | 7.155439e-3 |
GO:0002224 | toll-like receptor signaling pathway | 7.262414e-3 |
GO:0032728 | positive regulation of interferon-beta production | 7.267575e-3 |
GO:0008624 | induction of apoptosis by extracellular signals | 7.270025e-3 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 7.272970e-3 |
GO:0061036 | positive regulation of cartilage development | 7.323063e-3 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 7.323063e-3 |
GO:0006678 | glucosylceramide metabolic process | 7.491288e-3 |